May 09, 2017 7:51am EDT 22nd Century Raises 2017 Revenue Projection to $16Million – Another Record Year
May 08, 2017 4:15pm EDT 22nd Century Group Files 2017 First Quarter Report and Announces Conference Call to Provide Business Update
May 01, 2017 6:55am EDT FDA Authorizes Clinical Trial for 22nd Century’s BRAND B Low Tar-to-Nicotine Ratio Cigarettes
Apr 25, 2017 9:45am EDT 22nd Century Accepted to Present Proprietary Smoking Cessation Product at BIOCHINA Partnering Forum in Zhuhai, China
Apr 18, 2017 9:06am EDT World-Renowned Smoking Cessation Scientist, Dr. Michael Cummings, to Present Keynote Address at 22nd Century Annual Shareholder Meeting
Apr 04, 2017 9:45am EDT New Zealand Study Recommends 22nd Century’s VLN Cigarettes as an Effective Tobacco Control Strategy
Mar 30, 2017 9:50am EDT 22nd Century’s “Non- or Minimally-Addictive” Cigarettes Gaining Support of Leading Tobacco Scientists around the World
Mar 29, 2017 9:45am EDT 22nd Century Invited to Speak at the Colorado Hemp Expo about the Company’s Medical Marijuana Initiatives and Zero-THC Hemp Plants
